Quantcast

Latest Amyotrophic lateral sclerosis Stories

2014-05-16 08:27:03

/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr, will present at the World Stem Cells & Regenerative Medicine Congress, on Thursday, May 22, at 11:35 a.m. BST in London, UK (http://www.terrapinn.com/conference/stem-cells/index.stm). Neuralstem is currently in a Phase II clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its NSI-566 stem cells and has been approved to commence a Phase I study in spinal cord...

2014-05-14 23:05:42

RnRMarketResearch.com adds “EpiCast Report Amyotrophic Lateral Sclerosis & Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2023” to its store. Develop business strategies by understanding the trends shaping and driving the global ALS & CLL market. Dallas, Texas (PRWEB) May 14, 2014 EpiCast Report: Amyotrophic Lateral Sclerosis – Epidemiology Forecast to 2023 Amyotrophic lateral sclerosis (ALS), often referred to as “Lou Gehrig’s Disease,” is a rare, but...

2014-05-12 12:30:47

$100,000 prize and access to additional expertise awarded to support "big data" genetic analysis to provide new clues to the higher incidence of ALS in veterans BRIDGEWATER, N.J., May 12, 2014 /PRNewswire/ -- Sanofi US announced the winner of its second Innovation Challenge: Collaborate Innovate. The winner, Veterans Advancing ALS/MND, is a partnership that comprises Innovative Solutions Consortium and Johns Hopkins University. In the spirit of collaboration, Sanofi's Partners in Patient...

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-10 23:02:01

Fox Subacute Salutes the Strength of Those Diagnosed with ALS and Their Caregivers and Loved Ones; ALS Patient Care Burdens May Be Lessened with the Aid of a Subacute Facility Plymouth Meeeting, PA (PRWEB) May 10, 2014 On Monday, May 19th, Fox Subacute, the leader in ventilator and trach collar dependent patient care is sponsoring the Phillies Phestival at Citizens Bank Park. Join Fox Subacute in support of ALS. The gates open at 4:30pm and it runs till 7-8pm. Approximately 7,000 people...

2014-05-08 12:29:19

Papa John's Founder, Chairman and CEO John Schnatter Agrees to Serve as National Walk Ambassador WASHINGTON, May 8, 2014 /PRNewswire-USNewswire/ -- Papa John's International, based in Louisville, Kentucky, is helping The ALS Association raise awareness of amyotrophic lateral sclerosis (ALS) and boost participation the Walk to Defeat ALS®, which brings hope to those living with ALS and is an opportunity for individuals with the disease and their families and friends to spend a day...

2014-05-02 12:27:25

WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- William A. Thoet, Chairman of the Board of Trustees of The ALS Association, announced today that Barbara Newhouse has been named President and CEO of The Association after an extensive nationwide search. She will begin work on June 2, 2014. http://photos.prnewswire.com/prnvar/20140502/83774 ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the...

2014-04-29 12:33:11

Patients respond to ALS diagnosis by forming for-profit investment fund targeting a marketable cure for their disease AMSTERDAM, April 29, 2014 /PRNewswire/ -- On May 19th 2014, the founders of the fund will organise an ALS investors day, where they will reveal the blueprint of a revolutionary approach to find a marketable cure. The ALS investment fund will operate within an ecosystem that includes all necessary ingredients to bring a cure to patients, from a financial but also...

2014-04-29 08:36:49

GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment could significantly change the prognosis for everyone with the rare genetic disorder known as adrenoleukodystrophy, or ALD. The biotech company has recently celebrated a series of early successes in the treatment of other neurological conditions like ALS (Lou Gehrig's disease). Founder and CEO Jason Williams, M.D., believes his team is on the path toward a cure...

Gulf War Illness Likely Caused By Toxins - RAC Findings
2014-04-29 05:09:26

Brett Smith for redOrbit.com - Your Universe Online A new report from a Congressionally-mandated panel of scientific experts and veterans has found that Gulf War illness is most likely the result of exposure to toxins. The panel added research surrounding treatment of the condition has been advancing at an “encouraging” rate. Gulf War illness was established as a legitimate condition in 2008 by the same Research Advisory Committee on Gulf War Veterans' Illnesses (RAC) that presented...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related